A detailed history of Harvest Management LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Harvest Management LLC holds 225,000 shares of ITCI stock, worth $29.7 Million. This represents 13.33% of its overall portfolio holdings.

Number of Shares
225,000
Holding current value
$29.7 Million
% of portfolio
13.33%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$81.78 - $131.92 $18.4 Million - $29.7 Million
225,000 New
225,000 $29.7 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12.4B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Harvest Management LLC Portfolio

Follow Harvest Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Management LLC with notifications on news.